FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Perrigo H.E.B Allergy Relief Recall

H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistamine…

Perrigo Company PLC · Allegan, MI

Risk level
Class II
Reported by FDA
Jan 12, 2022
Recall ID
D-0340-2022
Check your lot numberHow we source this data

Summary

Perrigo recalled H.E.B Allergy Relief starting Jul 27, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0340-2022 on Jan 12, 2022. Reason: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Product description

H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistamine packaged as a) 15 count bottle, NDC 37808-571-22, UPC 0 41220 53081 6; b) 30 count bottle, NDC 37808-571-39, UPC 0 41220 53082 3; c) 45 count bottle, NDC 37808-571-95, UPC 0 41220 53083 0; Made with Pride & Care for H.E.B. San Antonio TX 78204, Product of Czech Republic,

Lot numbers, UPCs & expiration codes

Lot a) 0HE2530, Exp 12/31/2021; 0JE2407, Exp 2/28/2022: b) 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022: 0LR0363, Exp 6/30/2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0340-2022
Classification
Class II
Status
Terminated
Recall initiated
Jul 27, 2021
FDA report date
Jan 12, 2022
Quantity
13,920 containers
Recall type
Voluntary: Firm initiated
Recalling firm
Perrigo Company PLC

Original FDA data

Every field from FDA enforcement report D-0340-2022, exactly as published.

Show all FDA fields
City
Allegan
State
MI
Status
Terminated
Country
United States
Event ID
88384
Address
515 Eastern Ave
Code information
Lot a) 0HE2530, Exp 12/31/2021; 0JE2407, Exp 2/28/2022: b) 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022: 0LR0363, Exp 6/30/2022
Postal code
49010-9070
Report date
Jan 12, 2022
Product type
Drugs
Recall number
D-0340-2022
Classification
Class II
Recalling firm
Perrigo Company PLC
Product quantity
13,920 containers
Termination date
Nov 8, 2022
Reason for recall
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistamine packaged as a) 15 count bottle, NDC 37808-571-22, UPC 0 41220 53081 6; b) 30 count bottle, NDC 37808-571-39, UPC 0 41220 53082 3; c) 45 count bottle, NDC 37808-571-95, UPC 0 41220 53083 0; Made with Pride & Care for H.E.B. San Antonio TX 78204, Product of Czech Republic,
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 27, 2021
Initial firm notification
Letter
Center classification date
Jan 5, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0340-2022, published Jan 12, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls